Abstract
Present communication was focused on the ultrasonographic evaluation of the prokinetic effect of neostigmine in buffalo calves with abomasal atony. Six buffalo calves were selected for the study with absence of rumination, loss of feed intake, mild distended abdomen, achezia and frequent history of laying down and getting up with reduced rumen motility. Abomasal atony was confirmed by the ultrasonographic assessment of the abomasum motility. Calves were administered with injection neostigmine 0.02 mg/kg body weight slow intravenously along with 500 ml of 0.9% normal saline under the ultrasonographic monitoring. Abomasal motility was initiated by 18 to 42 minutes and complete abomasal motility was noticed by 150 to 180 minutes after administration of medications. Clinical improvement was noticed on the third day of therapy and efficacy of the neostigmine was noticed by ultrasonography. Present study concludes that neostigmine has prokinetic effect in buffalo calves with abomasal functional motility disorders. Ultrasonography is the best tool for assessment of abomasal motility without any adverse reactions and complications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
